VEGFA and neoplasm: Using human liposarcoma xenografts grown in nude mice, Trabectedin induces a significant decrease in the expression of relevant tumor mediators such as the chemokines CCL2 and CXCL8, IL-6 or the angiogenic factor VEGF, and an overall effect on the angiogenic network [42,67].